David A. Siegel Paratek Pharmaceuticals, Inc. Transaction History

Two Sigma Advisers, LP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$1.52 - $2.8 $38,000 - $70,000	25,000 Added 9.15%	298,300 $659,000
Q1 2023 May 15, 2023	SELL	$1.37 - $2.54 $117,409 - $217,678	-85,700 Reduced 23.87%	273,300 $694,000
Q4 2022 Feb 14, 2023	SELL	$1.67 - $2.51 $137,775 - $207,074	-82,500 Reduced 18.69%	359,000 $671,000
Q3 2022 Nov 14, 2022	BUY	$1.96 - $2.93 $554,092 - $828,311	282,700 Added 178.02%	441,500 $1.14 Million
Q2 2022 Aug 15, 2022	SELL	$1.73 - $3.09 $97,399 - $173,967	-56,300 Reduced 26.17%	158,800 $306,000
Q1 2022 May 16, 2022	SELL	$2.94 - $4.77 $295,764 - $479,861	-100,600 Reduced 31.87%	215,100 $639,000
Q4 2021 Feb 14, 2022	SELL	$4.07 - $5.3 $161,579 - $210,410	-39,700 Reduced 11.17%	315,700 $1.42 Million
Q3 2021 Nov 15, 2021	SELL	$4.7 - $7.24 $783,020 - $1.21 Million	-166,600 Reduced 31.92%	355,400 $1.73 Million
Q2 2021 Aug 16, 2021	BUY	$6.81 - $10.93 $8,853 - $14,209	1,300 Added 0.25%	522,000 $3.56 Million
Q1 2021 May 17, 2021	BUY	$6.14 - $8.31 $931,438 - $1.26 Million	151,700 Added 41.11%	520,700 $3.68 Million
Q4 2020 Feb 16, 2021	BUY	$4.58 - $7.14 $1.43 Million - $2.23 Million	312,200 Added 549.65%	369,000 $2.31 Million
Q3 2020 Nov 16, 2020	BUY	$4.19 - $6.69 $151,678 - $242,178	36,200 Added 175.73%	56,800 $307,000
Q2 2020 Aug 14, 2020	BUY	$2.97 - $5.22 $61,182 - $107,532	20,600 New	20,600 $108,000

1.54M

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.